GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eyebright Medical Technology (Beijing) Co Ltd (SHSE:688050) » Definitions » Equity-to-Asset

Eyebright Medical Technology (Beijing) Co (SHSE:688050) Equity-to-Asset : 0.69 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Eyebright Medical Technology (Beijing) Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Eyebright Medical Technology (Beijing) Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥2,448 Mil. Eyebright Medical Technology (Beijing) Co's Total Assets for the quarter that ended in Mar. 2025 was ¥3,536 Mil. Therefore, Eyebright Medical Technology (Beijing) Co's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.69.

The historical rank and industry rank for Eyebright Medical Technology (Beijing) Co's Equity-to-Asset or its related term are showing as below:

SHSE:688050' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.66   Med: 0.83   Max: 0.95
Current: 0.69

During the past 9 years, the highest Equity to Asset Ratio of Eyebright Medical Technology (Beijing) Co was 0.95. The lowest was 0.66. And the median was 0.83.

SHSE:688050's Equity-to-Asset is ranked better than
57.75% of 871 companies
in the Medical Devices & Instruments industry
Industry Median: 0.63 vs SHSE:688050: 0.69

Eyebright Medical Technology (Beijing) Co Equity-to-Asset Historical Data

The historical data trend for Eyebright Medical Technology (Beijing) Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eyebright Medical Technology (Beijing) Co Equity-to-Asset Chart

Eyebright Medical Technology (Beijing) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.93 0.82 0.83 0.70 0.69

Eyebright Medical Technology (Beijing) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 0.66 0.68 0.69 0.69

Competitive Comparison of Eyebright Medical Technology (Beijing) Co's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Eyebright Medical Technology (Beijing) Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eyebright Medical Technology (Beijing) Co's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eyebright Medical Technology (Beijing) Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Eyebright Medical Technology (Beijing) Co's Equity-to-Asset falls into.


;
;

Eyebright Medical Technology (Beijing) Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Eyebright Medical Technology (Beijing) Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=2409.498/3496.968
=0.69

Eyebright Medical Technology (Beijing) Co's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=2448.033/3536.076
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eyebright Medical Technology (Beijing) Co  (SHSE:688050) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Eyebright Medical Technology (Beijing) Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Eyebright Medical Technology (Beijing) Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Eyebright Medical Technology (Beijing) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 9, Xingchang Road, Science and Technology Park, Changping District, Beijing, CHN, 102200
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
Executives
Jia Bao Shan senior management
Wang Zhao Directors, senior managers, core technical personnel
Jie Jiang Bing Directors, senior managers, core technical personnel

Eyebright Medical Technology (Beijing) Co Headlines

No Headlines